Markets:

Overview

News

Currencies

International

Treasuries

Provention Bio, Inc. - Common Stock (NQ:PRVB)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Apr 26, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Provention Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Earnings Preview For Provention Bio ↗

August 03, 2022

Provention Bio (NASDAQ:PRVB) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's what investors need to know before the announcement. Analysts estimate that Provention...

Via Benzinga

The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug ↗

July 08, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact ↗

July 01, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

U.S. FDA Extends Review By Three Months For Provention Bio's Type 1 Diabetes Candidate ↗

June 30, 2022

The U.S. Food and Drug Administration (FDA) has extended its review period by three months for Provention Bio’s (NASDAQ: PRVB) Biologics License Application (BLA) for teplizumab in patients with type 1...

Via Benzinga

FDA Gives Green Signal To Provention Bio's Delaying Diabetes Med Resubmission ↗

January 28, 2022

Provention Bio Inc (NASDAQ: PRVB) said that it had resolved the comparability concerns with the FDA, and

Via Benzinga

Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday ↗

July 05, 2022

Gainers Omeros Corporation (NASDAQ: OMER) jumped 68.7% to close at $4.64. Clovis Oncology, Inc. (NASDAQ: CLVS) gained 58.3% to settle at $2.85 on Friday.

Via Benzinga

Provention Bio Earnings Conference Call Is Coming Up, Here's What You Need To Know ↗

April 28, 2022

Provention Bio (NASDAQ:PRVB) will host a conference call at 08:00 AM ET on May 5, 2022, to discuss Q1 2022 earnings results. How to Attend Provention Bio (PRVB) Conference Call Follow this link to...

Via Benzinga

Provention Bio's Coxsackievirus Vaccine Candidate Elicits Durable Virus-Neutralizing Antibodies At Six Months ↗

March 28, 2022

Provention Bio Inc (NASDAQ: PRVB) announced

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

February 24, 2022

Gainers Lantheus Holdings (NASDAQ:LNTH) stock rose 33.3% to $38.46 during Thursday's regular session. The current volume of 3.4 million shares is 876.7% of Lantheus...

Via Benzinga

Provention Bio Resubmits Teplizumab Application In US For Type-1 Diabetes ↗

February 22, 2022

Provention Bio Inc (NASDAQ: PRVB) has resubmitted the Biologics License Application (BLA) for teplizumab for the delay of clinical type 1 diabetes (T1D) in at-risk...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

February 03, 2022

Gainers Cidara Therapeutics (NASDAQ:CDTX)...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 31, 2022

Gainers Calithera Biosciences (NASDAQ:CALA) shares moved upwards by 42.8% to $0.6 during Monday's regular session. As of 12:30 EST, Calithera Biosciences's stock...

Via Benzinga

64 Biggest Movers From Yesterday ↗

February 01, 2022

Gainers Calithera Biosciences, Inc. (NASDAQ: CALA) shares surged 55.7% to settle at $0.65 on Monday after Ladenburg Thalmann initiated coverage on the stock with a...

Via Benzinga

Looking Into Provention Bio Inc's Recent Short Interest ↗

January 31, 2022

Provention Bio Inc's (NASDAQ:PRVB) short percent of float has risen 4.37% since last its last report. The company recently reported that it has 3.31 million shares sold short,...

Via Benzinga

Mid-Afternoon Market Update: Gold Records Lowest Finish In Over Six Weeks; Clearfield Shares Gain On Upbeat Results ↗

January 28, 2022

US stocks gained toward the end of trading session after opening on a weak note. Apple Inc. (NASDAQ: AAPL) reported better-than-expected earnings results for its first quarter...

Via Benzinga

52 Biggest Movers From Friday ↗

January 31, 2022

Gainers Knightscope, Inc. (NASDAQ: KSCP) surged 175.6% to close at $3.40 on Friday. The company, on Thursday, priced its IPO at $10 per share. Imperial Petroleum Inc. (NASDAQ:...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

January 28, 2022

Gainers Provention Bio (NASDAQ:PRVB) stoc...

Via Benzinga

Mid-Day Market Update: US Stocks Turn Positive; Nasdaq Surges 2% ↗

January 28, 2022

US stocks turned higher, with all the three major indices recording gains. The Nasdaq climbed more than 2% following stronger-than-expected earnings results from Apple Inc. (...

Via Benzinga

33 Stocks Moving In Friday's Mid-Day Session ↗

January 28, 2022

Gainers Imperial Petroleum Inc. (NASDAQ: IMPP) shares jumped 126% to $2.6219. Imperial Petroleum, last month, posted Q3 revenue of $4.1 million. Yoshitsu Co., Ltd (NASDAQ: TKLF...

Via Benzinga

The Daily Biotech Pulse: Biogen Liquidates Out Of Biosimilar JV, Provention Bio Plots Diabetes Drug Resubmission, Merck Finds COVID Pill Effective Against Omicron ↗

January 28, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

January 28, 2022

Gainers Provention Bio (NASDAQ:PRVB) shares increased by 16.8% to $3.97 during Friday's pre-market session. The market value of their outstanding shares is at $251.5...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

January 28, 2022

Good morning, investor! The week is almost done but we're not slacking as we check out the biggest pre-market stock movers for Friday!

Via InvestorPlace

21 Stocks Moving in Friday's Pre-Market Session ↗

January 28, 2022

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep. Check out these penny stocks insiders are buying Losers...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

January 27, 2022

Gainers Avidity Biosciences (NASDAQ:RNA) s...

Via Benzinga

Provention Bio Starts Mid-Stage Lupus Trial; Data Expected In 2024 ↗

January 21, 2022

Provention Bio Inc (NASDAQ: PRVB) has initiated the Phase 2a PREVAIL-2 study evaluating PRV-3279 in systemic lupus erythematosus (SLE). PRV-3279 is a humanized...

Via Benzinga

61 Biggest Movers From Yesterday ↗

November 23, 2021

Gainers Longeveron Inc. (NASDAQ: LGVN) shares surged 181.2% to settle at $28.20 on Monday on continued upward momentum after the company last week announced the FDA granted Rare...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

January 19, 2022

During Wednesday's morning trading, 400 companies set new 52-week lows. 52-Week Low Highlights: Intuitive Surgical (NASDAQ:ISRG) was the largest company by...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 22, 2021

Gainers iSpecimen (NASDAQ:ISPC) stock moved upwards by 95.32% to $9.61 during Monday's regular session. Trading volume for iSpecimen's stock is 70.9 million as of...

Via Benzinga

Provention Bio Shares Gain On Teplizumab Regulatory Update For Type 1 Diabetes ↗

November 22, 2021

The FDA has approved Provention Bio Inc's (NASDAQ: PRVB) proceeding to populate the popPK model with data collected from patients receiving therapeutic...

Via Benzinga

40 Stocks Moving In Monday's Mid-Day Session ↗

November 22, 2021

Gainers iSpecimen Inc. (NASDAQ: ISPC) shares climbed 126.5% to $11.12 after the company announced it has been contracted to support new advanced research on COVID-19 seeking...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Provention Bio, Inc. - Common Stock (NQ:PRVB)

All News about Provention Bio, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today